Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Mini Test Dose of Intravenous Busulfan (Busulfex®) in Allogeneic Non-Myeloablative Stem Cell Transplantation, Followed by Liquid Chromatography Tandem-Mass Spectrometry

Ivan Spasojevic, PhD, Ligia R. S. da Costa, MD, Mitchell E. Horwitz, MD, Gwynn D. Long, MD, Keith M. Sullivan, MD, John P. Chute, MD, Cristina Gasparetto, MD, Ashley Morris, PharmD, Nelson J. Chao, MD, David A. Rizzieri, MD

Blood (2011) 118 (21): 4566.

https://doi.org/10.1182/blood.V118.21.4566.4566

Published: 2011

Journal Articles

The Impact of Lymphocyte Subset Recovery At 3 Months on Progression-Free Survival After Myeloablative Allogeneic Stem Cell Transplantation,

Junya Kanda, MD, David A. Rizzieri, MD, Gwynn D. Long, MD, Cristina Gasparetto, MD, John P. Chute, MD, Keith M. Sullivan, MD, Ashley Morris, PharmD, Jacalyn McPherson, J. Andrew Livingston, MD, Gloria Broadwater, MS, Donna Niedzwiecki, PhD, Nelson J. Chao, MD, Mitchell E. Horwitz, MD

Blood (2011) 118 (21): 4065.

https://doi.org/10.1182/blood.V118.21.4065.4065

Published: 2011

Journal Articles

Prospective, Biological Randomized Study of T-Cell Depleted Nonmyeloablative Allogeneic Transplantation From HLA-Matched Related, Unrelated or Haploidentical Donors for Patients with Hematologic Malignancies

Junya Kanda, MD, Gwynn D. Long, MD, Cristina Gasparetto, MD, Mitchell E. Horwitz, MD, Keith M. Sullivan, MD, John P. Chute, MD, Ashley Morris, PharmD, Zhiguo Li, PhD, Nelson J. Chao, MD, David A. Rizzieri, MD

Blood (2010) 116 (21): 3541.

https://doi.org/10.1182/blood.V116.21.3541.3541

Published: 2010

Journal Articles

Adult Dual Umbilical Cord Blood Transplantation Using Myeloablative Total Body Irradiation (1350cGy) and Fludarabine Conditioning

Junya Kanda, MD, David A. Rizzieri, MD, Cristina Gasparetto, MD, Gwynn D. Long, MD, John P. Chute, MD, Keith M. Sullivan, MD, Ashley Morris, PharmD, Clayton A. Smith, MD, FRCPC, Donna E. Hogge, MD, PhD, Janet Nitta, Kevin Song, MD, Donna Niedzwiecki, PhD, Nelson J. Chao, MD, Mitchell E. Horwitz, MD

Blood (2010) 116 (21): 3523.

https://doi.org/10.1182/blood.V116.21.3523.3523

Published: 2010

Journal Articles

Safety Trial of NK Cell Enhanced Donor Lymphocyte Infusions from a 3-5/6 HLA Matched Family Member Following Nonmyeloablative Allogeneic Stem Cell Transplantation

David A. Rizzieri, MD, Robert Storms, Ph.D, Daniel Nikcevich, MD, PhD, Bercedis Peterson, Ph.D, Debashish Misra, MD, Christine Apple, Megan Baker, Cristina Gasparetto, MD, Mitchell Horwitz, MD, John Chute, MD, Ashley Morris, PharmD., Nelson J. Chao, MD

Blood (2008) 112 (11): 342.

https://doi.org/10.1182/blood.V112.11.342.342

Published: 2008

Journal Articles

Myeloablative Intravenous Busulfan/Fludarabine Conditioning Does Not Facilitate Reliable Engraftment of Dual Umbilical Cord Blood Grafts in Adult Recipients.

Mitchell Horwitz, MD, John Chute, MD, Cristina Gasparetto, MD, Gwynn Long, MD, David Rizzieri, MD, Ashley Morris, PharmD, Jackie McPherson, Keith Sullivan, MD, Nelson Chao, MD

Blood (2007) 110 (11): 2007.

https://doi.org/10.1182/blood.V110.11.2007.2007

Published: 2007

Journal Articles

Adult Umbilical Cord Blood Transplantation Following Non-Myeloablative Conditioning; Impact of Increased Cell Dose and 200cGy TBI on Engraftment and Survival.

Mitchell Horwitz, MD, David Rizzieri, MD, Gwynn D. Long, MD, Cristina Gasparetto, MD, Ashley Morris, PharmD, Keith Sullivan, MD, John Chute, MD, Dawn Marshall, Nelson Chao, MD

Blood (2006) 108 (11): 5399.

https://doi.org/10.1182/blood.V108.11.5399.5399

Published: 2006

NARROW

Mini Test Dose of Intravenous Busulfan (Busulfex®) in Allogeneic Non-Myeloablative Stem Cell Transplantation, Followed by Liquid Chromatography Tandem-Mass Spectrometry

The Impact of Lymphocyte Subset Recovery At 3 Months on Progression-Free Survival After Myeloablative Allogeneic Stem Cell Transplantation,

Prospective, Biological Randomized Study of T-Cell Depleted Nonmyeloablative Allogeneic Transplantation From HLA-Matched Related, Unrelated or Haploidentical Donors for Patients with Hematologic Malignancies

Adult Dual Umbilical Cord Blood Transplantation Using Myeloablative Total Body Irradiation (1350cGy) and Fludarabine Conditioning

Safety Trial of NK Cell Enhanced Donor Lymphocyte Infusions from a 3-5/6 HLA Matched Family Member Following Nonmyeloablative Allogeneic Stem Cell Transplantation

Myeloablative Intravenous Busulfan/Fludarabine Conditioning Does Not Facilitate Reliable Engraftment of Dual Umbilical Cord Blood Grafts in Adult Recipients.

Adult Umbilical Cord Blood Transplantation Following Non-Myeloablative Conditioning; Impact of Increased Cell Dose and 200cGy TBI on Engraftment and Survival.

Email alerts

ASH Publications

American Society of Hematology

Mini Test Dose of Intravenous Busulfan (Busulfex®) in Allogeneic Non-Myeloablative Stem Cell Transplantation, Followed by Liquid Chromatography Tandem-Mass Spectrometry

The Impact of Lymphocyte Subset Recovery At 3 Months on Progression-Free Survival After Myeloablative Allogeneic Stem Cell Transplantation,

Prospective, Biological Randomized Study of T-Cell Depleted Nonmyeloablative Allogeneic Transplantation From HLA-Matched Related, Unrelated or Haploidentical Donors for Patients with Hematologic Malignancies

Adult Dual Umbilical Cord Blood Transplantation Using Myeloablative Total Body Irradiation (1350cGy) and Fludarabine Conditioning

Safety Trial of NK Cell Enhanced Donor Lymphocyte Infusions from a 3-5/6 HLA Matched Family Member Following Nonmyeloablative Allogeneic Stem Cell Transplantation

Myeloablative Intravenous Busulfan/Fludarabine Conditioning Does Not Facilitate Reliable Engraftment of Dual Umbilical Cord Blood Grafts in Adult Recipients.

Adult Umbilical Cord Blood Transplantation Following Non-Myeloablative Conditioning; Impact of Increased Cell Dose and 200cGy TBI on Engraftment and Survival.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only